Daniel DiMaio

11.7k citations
168 papers · 9.5k indexed · 2 hit papers · h-index 50

Impact in

  • Genetics top 0.5%
    • Virus-based gene therapy research
  • Immunology top 1%
    • interferon and immune responses

Papers in

    • Virus-based gene therapy research 81
    • T-cell and Retrovirus Studies 14
    • interferon and immune responses 13

Daniel DiMaio

165 papers receiving 9.2k citations

Hit Papers

Senescence‐associated β‐galactosidase is lysosomal β‐galactosidase 2006 · 1.1k citations
1.1k19832026199720112505007501000

Peers

Daniel DiMaio
Comparison fields: 5 of 130
  • Genetics 2.7k
  • Immunology 1.9k
  • Oncology 2.3k
  • Epidemiology 2.9k
  • Aging 138
Replace Jon M. Huibregtse with:
Jon M. Huibregtse United States
Louise T. Chow United States
Martin Scheffner Germany
Michael B. Mathews United States
Lawrence Banks Italy
James C. Alwine United States
Ed Harlow United States
Biao He United States
Michael R. Botchan United States
Makoto Miyagishi Japan
Daniel DiMaio relative to Jon M. Huibregtse United States Jon M. Huibregtse's profile →
Citations per field
00.5×3.1×
Jon M. Huibregtse · 1×
Citations per year

Countries citing papers authored by Daniel DiMaio

Since Specialization
Citations

This map shows the geographic impact of Daniel DiMaio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel DiMaio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel DiMaio more than expected).

Fields of papers citing papers by Daniel DiMaio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel DiMaio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel DiMaio. The network helps show where Daniel DiMaio may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Daniel DiMaio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel DiMaio Line = papers co-authored together Daniel DiMaio links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 20247
4 20231
5 202310
6 201623
7 20136
8 2013202
9 201032
10 20105
11 200858
12 200784
13 200646
14
Cancer issue: The War on Cancer: An Update from the New Haven Theater of Operations
20061
15 20034
16 1995107
17 199571
18 199014
19 19896
20 198849

About Daniel DiMaio

Daniel DiMaio is a scholar working on Genetics, Immunology, Epidemiology, Virology and Oncology, having authored 168 papers that have together received 9.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (81 papers), Cervical Cancer and HPV Research (41 papers), Molecular Biology Techniques and Applications (20 papers), Cancer-related Molecular Pathways (15 papers), Bacteriophages and microbial interactions (15 papers), T-cell and Retrovirus Studies (14 papers), RNA and protein synthesis mechanisms (14 papers) and interferon and immune responses (13 papers). The work is most often cited by research in Genetics (2.7k citations), Immunology (1.9k citations), Oncology (2.3k citations), Epidemiology (2.9k citations) and Aging (138 citations). Daniel DiMaio has collaborated with scholars based in United States, United Kingdom and Russia. Frequent co-authors include Edward C. Goodwin, Tom Maniatis, Kai Zinn, Lisa M. Petti, Daniel Nathans, Eun Seong Hwang, Kimberly L. Johung, Laura A. Nilson, Wim J. Kleijer and Amelia Morrone. Their work appears in journals such as Journal of Virology, Proceedings of the National Academy of Sciences, Molecular and Cellular Biology, Virology and PLoS Pathogens.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026